Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Latest Articles

  • You have access
    Prognostic Impact of Residual T and N Status After Neoadjuvant Therapy in Breast Cancer
    SAE FUJIOKA, SHINICHIRO KASHIWAGI, YUKO KIKUKAWA, CHIKA WATANABE, KOJI TAKADA, YUKIE TAUCHI, KANA OGISAWA, MASATSUNE SHIBUTANI, HARUHITO KINOSHITA, TAMAMI MORISAKI and KEIKO YOSHIMURA
    Anticancer Research February 2026, 46 (2) 939-947; DOI: https://doi.org/10.21873/anticanres.18000
  • You have access
    Synergistic Effects of Honokiol on Camptothecin-triggered Apoptosis of Drug-resistant Glioblastoma Cells via CDK1-mediated G2/M Arrest and Intrinsic ROS-Mitochondrion-dependent Pathway
    CHIH-PIN YANG, JUI-TAI CHEN, SHING-HWA LIU, EDWIN CHEN and RUEI-MING CHEN
    Anticancer Research February 2026, 46 (2) 633-649; DOI: https://doi.org/10.21873/anticanres.17975
  • You have access
    Prognostic Significance of Extrapancreatic Invasion in Pancreatic Cancer: Excellent Outcomes in Patients With Disease Confined Within the Pancreas
    RYO SAITO, HIDETAKE AMEMIYA, WATARU IZUMO, TAISHU OKA, SUGURU MARUYAMA, KOICHI TAKIGUCHI, KATSUTOSHI SHODA, KENSUKE SHIRAISHI, SHINJI FURUYA, YOSHIHIKO KAWAGUCHI, HIROMICHI KAWAIDA and DAISUKE ICHIKAWA
    Anticancer Research February 2026, 46 (2) 1089-1096; DOI: https://doi.org/10.21873/anticanres.18011
  • Open Access
    Corrigendum
    Anticancer Research February 2026, 46 (2) 1173; DOI: https://doi.org/10.21873/anticanres.18020
  • Open Access
    Extracellular cGMP Levels Predict the Response of C4-1 Cervical Cancer Cells to Ionizing Radiation
    GEORG SAGER, MARIT LIVIK, TURID HELLEVIK and ANNE ØRBO
    Anticancer Research February 2026, 46 (2) 611-618; DOI: https://doi.org/10.21873/anticanres.17973
  • You have access
    Oncogenic Role and Clinical Significance of NPM1 in Colorectal Cancer via the AKT/mTOR Signaling Pathway
    HONG-BEUM KIM, HEE-JEONG LEE and SANG-GON PARK
    Anticancer Research February 2026, 46 (2) 727-736; DOI: https://doi.org/10.21873/anticanres.17982
  • You have access
    Clinicopathological Significance of HER2 Expression Redefined by the HER2-low Concept in Ductal Carcinoma In Situ
    KOJI TAKADA, SHINICHIRO KASHIWAGI, MAYUKO HIRATA, MARIKO NISHIKAWA, CHIKA WATANABE, YUKIE TAUCHI, KANA OGISAWA, MASATSUNE SHIBUTANI, HARUHITO KINOSHITA and TAMAMI MORISAKI
    Anticancer Research February 2026, 46 (2) 901-909; DOI: https://doi.org/10.21873/anticanres.17997
  • You have access
    Lenvatinib Exhibits Potent Anti-tumor Activity and Favorable Safety Profile in a Colorectal Cancer Xenograft Model
    CHEN-YU KUO, TSAI-LAN LIAO, FEI-TING HSU, CHING MING CHANG and JING-JIM OU
    Anticancer Research February 2026, 46 (2) 797-810; DOI: https://doi.org/10.21873/anticanres.17988
  • You have access
    Awareness, Utilization, and Barriers to Fluorescence Ureteral Navigation in Japan: A Nationwide Survey Study
    SHUNJIN RYU, YUTA IMAIZUMI, SHUNSUKE NAKASHIMA, HYUGA KAWAKUBO, HIRONARI KAWAI, DAIKI SUZUKI, RYUSUKE ITO, KEISUKE GOTO, TEPPEI KAMADA and KEN ETO
    Anticancer Research February 2026, 46 (2) 1131-1141; DOI: https://doi.org/10.21873/anticanres.18016
  • You have access
    Treatment Patterns and Prognostic Factors of Anti-HER2 Therapy in HER2-positive Advanced/Recurrent Gastric Cancer
    NORIKO WADA, YUKINORI KUROKAWA, TSUYOSHI TAKAHASHI, TAKURO SAITO, TAKAOMI HAGI, SHIGETO NAKAI, KOTA MOMOSE, KOTARO YAMASHITA, KOJI TANAKA, TOMOKI MAKINO, HIDETOSHI EGUCHI, YUICHIRO DOKI and TAROH SATOH
    Anticancer Research February 2026, 46 (2) 949-961; DOI: https://doi.org/10.21873/anticanres.18001

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 1773
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire